While SRT holds promise, it also has limitations and potential risks:
Incomplete Efficacy: SRT may not completely halt substrate accumulation, especially if the disease is already advanced. Side Effects: Inhibitors used in SRT can have off-target effects, leading to adverse reactions in some patients. Not a Cure: SRT manages symptoms but does not cure the underlying genetic defect causing the disorder.
